Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ranibizumab treatment of patients with ocular diseases.

× No keyword cloud information.

8 in total

Review 1. Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

Authors: Mary Elizabeth Hartnett
Journal: Trans Am Ophthalmol Soc Date: 2010-12

Review 2. Vascular endothelial growth factor in eye disease.

Authors: J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal: Prog Retin Eye Res Date: 2008-05-28 Impact factor: 21.198

3. Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells.

Authors: Abouzar Bagheri; Zahra-Soheila Soheili; Hamid Ahmadieh; Shahram Samiei; Nader Sheibani; Shamila Darvishalipour Astaneh; Mozhgan Rezaei Kanavi; Azam Mohammadian
Journal: Mol Vis Date: 2015-04-10 Impact factor: 2.367

4. Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats.

Authors: Young-Giun Kim; Hyung-Ho Lim; Suh-Ha Lee; Mal-Soon Shin; Chang-Ju Kim; Hyeon Jeong Yang
Journal: Mol Med Rep Date: 2015-04-15 Impact factor: 2.952

Review 5. Intravitreal bevacizumab as anti-vascular endothelial growth factor in the management of complications of proliferative diabetic retinopathy.

Authors: J Fernando Arevalo
Journal: Med Hypothesis Discov Innov Ophthalmol Date: 2013

6. Factors Impacting Efficacy of AAV-Mediated CRISPR-Based Genome Editing for Treatment of Choroidal Neovascularization.

Authors: Sook Hyun Chung; Iris Natalie Mollhoff; Uyen Nguyen; Amy Nguyen; Natalie Stucka; Eric Tieu; Suman Manna; Ratheesh Kumar Meleppat; Pengfei Zhang; Emerald Lovece Nguyen; Jared Fong; Robert Zawadzki; Glenn Yiu
Journal: Mol Ther Methods Clin Dev Date: 2020-01-23 Impact factor: 6.698

7. Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity.

Authors: P Geisen; L J Peterson; D Martiniuk; Ahbineet Uppal; Y Saito; M Elizabeth Hartnett
Journal: Mol Vis Date: 2008-02-11 Impact factor: 2.367

Review 8. Neuroinflammatory responses in diabetic retinopathy.

Authors: Ying Yu; Hui Chen; Shao Bo Su
Journal: J Neuroinflammation Date: 2015-08-07 Impact factor: 8.322

8 in total